Natural killer cell activation in the lung allograft early posttransplantation

Transplantation

Volumn 89, Issue 6, 2010, Pages 756-763

  Meehan, Aislin C ^a   Sullivan, Lucy C ^b   Mifsud, Nicole A ^a   Brooks, Andrew G ^b   Snell, Greg I ^a   Kotsimbos, Tom C ^a   Westall, Glen P ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Human; Lung.; Natural killer cells; Transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CD56 ANTIGEN; CYCLOSPORIN; GANCICLOVIR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; PREDNISOLONE; TACROLIMUS; VALGANCICLOVIR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; ANTIGENS, CD56; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; K562 CELLS; KILLER CELLS, NATURAL; LIGANDS; LONGITUDINAL STUDIES; LUNG TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, KIR; TIME FACTORS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77949896839     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181cab17f     Document Type: Article

References (33)

1. Hamerman JA, Ogasawara K, Lanier LL. NK cells in innate immunity. Curr Opin Immunol 2005; 17: 29.
2. Caligiuri MA. Human natural killer cells. Blood 2008; 112: 3.
3. Moretta A, Bottino C, Mingari MC, et al. What is a natural killer cell? Nat Immunol 2002; 3: 6.
4. Cooper MA, Fehniger TA, Caligiuri MA. The biology of natural killer-cell subsets. Trends Immunol 2001; 22: 633.
5. Colucci F, Caliguri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol 2003; 3: 413.
6. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005; 5: 201.
7. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001; 19: 291.
8. Anfossi N, Andre P, Guia S, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006; 25: 331.
9. Lanier LL, Le AM, Civin CI, et al. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986; 136: 4480.
10. bright subset. Blood 2001; 97: 10.
11. Poli A, Michel T, Theresine M, et al. CD56bright natural killer (NK) cells: An important NK cell subset. Immunology 2009; 126: 458.
12. Nagler A, Lanier LL, Cwirla S, et al. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989; 143: 3183.
13. Cheent K, Khakoo SI. Natural killer cells: Integrating diversity with function. Immunology 2009; 126: 449.
14. Khakoo SI, Thio CL, Martin MP, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004; 305: 872.
15. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR 3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31: 429.
16. Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 1.
17. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097.
18. Fildes JE, Yonan N, Tunstall K, et al. Natural killer cells in peripheral blood and lung tissue are associated with chronic rejection after lung transplantation. J Heart Lung Transplant 2008; 27: 203.
19. Fildes JE, Yonan N, Leonard CT. Natural killer cells and lung transplantation, roles in rejection, infection and tolerance. Transpl Immunol 2008; 19: 1.
20. Kitchens WH, Uehara S, Chase CM, et al. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006; 81: 811.
21. Kunert K, Seiler M, Mashreghi MF, et al. KIR/HLA ligand incompatibility in kidney transplantation. Transplantation 2007; 84: 1527.
22. Hadaya K, de Rham C, Bandelier C, et al. Natural killer cell repertoire and their ligands, and the risk of CMV infection after kidney transplantation. Am J Transplant 2008; 8: 2674.
23. Beilke JN, Kuhl NR, Van Kaer L, et al. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2005; 11: 1059.
24. Yu G, Xu X, Vu MD, et al. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med2006; 203: 1851.
25. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1229.
26. Delfino L, Morabito A, Pera C, et al. Sequence-based typing for HLA-C, medium size PCR protocol. In: Tilanus MG, Hansen JH, Hurley CK, eds. IHWG Technical Manual Genomic Analysis of the Human MHC: DNA-Based Typing for HLA Alleles and Linked Polymorphisms. Seattle, WA: Fred Hutchinson Cancer Research Center; 2000.
27. Zheng L, Orsida B, Whitford H, et al. Longitudinal comparisons of lymphocytes and subtypes between airway wall and bronchoalveolar lavage after human lung transplantation. Transplantation 2005; 80: 185.
28. im NK cells. Scand J Immunol 2007; 656: 126.
29. Pascal V, Schleinitz N, Brunet C, et al. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. Eur J Immunol 2004; 34: 2930.
30. + natural killer cell subpopulations. Blood 2007; 110: 1530.
31. Ouyang Q, Baerlocher G, Vulto I, et al. Telomere length in human natural killer cell subsets. Ann N Y Acad Sci 2007; 1106: 240.
32. Kroemer A, Edtinger K, Li X. The innate natural killer cells in transplant rejection and tolerance induction. Curr Opin Organ Transplant 2008; 13: 339.
33. Vacher-Coponat H, Brunet C, Moal V, et al. Tacrolimus/mycopheno-late mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. Transplantation 2006; 82: 558.